patients seeking cross-border GLP-1 access found (Kesselheim et al., JAMA Health Forum, 2024): 23% attempted to order from a Canadian online pharmacy (87% of orders were either seized at customs, never delivered, or delivered a product that was clearly counterfeit) 12% traveled to a border city and attempted to fill a prescription (91% were turned away because they lacked a valid Canadian prescription) 8% used a "facilitator" service claiming to connect them with Canadian prescribers (62% received no product, 31% received a product of uncertain origin, 7% received what appeared to be legitimate medication) The risk-benefit calculus is unfavorable
A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis C virus cirrhosis
These characteristics, together with batch-specific documentation, support accurate material identification and traceability within controlled laboratory workflows
A new experimental treatment is drawing attention after Phase 3 results showed that patients lost up to 28.3 percent of their body weight, one of the most significant reductions seen with an obesity medication to date
This limits foaming and shear stress on the peptide
BPC-157 is often considered for recovery-oriented protocols involving muscles, tendons, ligaments, and joints
